Markets.com Logo

GALT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.8495$
  • Previous Close
    3.8495$
  • 52 Week Change
    3.68$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.726$ - 4.41$
  • Dividend Per Share
    --
  • Market cap
    249 M$
  • EPS
    -0.12
  • Beta
    0.827
  • Volume
    --

About

GALT.US refers to Galectin Therapeutics Inc., a biotechnology company focused on developing therapies for fibrotic and inflammatory diseases, including non-alcoholic steatohepatitis (NASH) with cirrhosis and cancer. The ".US" suffix indicates that this stock is traded on a United States stock exchange, typically the Nasdaq or NYSE. Investors can purchase and trade shares of Galectin Therapeutics Inc. under this ticker symbol on these exchanges. It is important to note that stock prices can fluctuate significantly based on various factors, including company performance, industry trends, and overall market conditions.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Company Performance: Galectin Therapeutics' financial health, including revenue, profitability, and cash flow, directly impacts its stock price.

Clinical Trial Results: As a biotechnology company, results from clinical trials of its drug candidates, like Belapectin, significantly influence investor sentiment and stock value.

Regulatory Approvals: FDA decisions regarding Belapectin or other pipeline drugs can trigger major price swings, depending on approval or rejection.

Market Sentiment: Overall investor mood towards the biotechnology sector or small-cap stocks can affect GALT.US, regardless of company-specific news.

Partnerships & Licensing: Announcements of collaborations or licensing agreements can boost investor confidence and increase the stock price.

Competition: Advances by competitors in the NASH or oncology fields may negatively impact GALT.US as investors re-evaluate market share potential.

Economic Conditions: Broader economic factors like interest rates and inflation can affect overall market valuations, including GALT.US.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--